CMS understands that not all physicians will report quality measures under the Medicare Access and CHIP Reauthorization Act or join advanced alternative payment models, especially immediately, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS. However, there are efforts in place to make it as easy as possible for these providers, which will hopefully increase participation over time.
CMS understands that not all physicians will report quality measures under the Medicare Access and CHIP Reauthorization Act (MACRA) or join advanced alternative payment models (APMs), especially immediately, said Kate Goodrich, MD, director of the Quality Measurement and Value-Based Incentives Group in CMS. However, there are efforts in place to make it as easy as possible for these providers, which will hopefully increase participation over time.
Transcript (slightly modified)
Is there a percentage of physicians that you expect will not report at least one quality measure under MACRA and will be facing penalties?
We hope that that number is minimal. We really, again, our goal is to have very high participation in this program, but certainly there are likely to be at least some clinicians who make the decision, that for whatever reason, that they don’t want to participate in the program. There may be some clinicians who aren’t aware of the program who don’t participate, although we’re really working hard to get the word out to every physician and eligible clinician in the country about this, using a lot of our surrogates and counting on the specialty societies and state medical societies to help with that.
But certainly, there is likely to be what we hope is a very small percentage of people who don’t do anything, and if you don’t participate at all, don’t send in any data, and you are eligible for the program, so you don’t go below the low-volume threshold for example, then you will get a 4% penalty.
How many physicians do you expect will be in advanced APMs under MACRA?
We think for 2017 that the number of clinicians that will be in advanced APMs is somewhere probably between 90,000 and 120,000. We hope that that number, we’re aiming for that number to increase significantly by 2018, so we could have as many as 200,000 to 250,000 clinicians be in advanced APMs.
Now again, remember in order for them to be exempt from MIPS [Merit-based Incentive Payment System] they have to have a certain percentage of their revenue from Medicare coming through that advanced APM, or a certain percentage of their patients being attributed to that advanced APM. But we’re optimistic with some of the things that we do plan to put in place over the next year, that will allow more and more clinicians to be eligible for these advanced APMs.
And then over time, of course, we anticipate that growing even further, particularly as the Physician Technical Advisory Committee, or the PTAC, is receiving applications for new physician-focused payment models. We anticipate a lot of those are going to be specialty focused, and many of those we hope will ramp up over time so those numbers will grow even more.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More